Post Profile






Montel Williams Uses SafSlim Supplement to Manage His Weight and MS Symptoms

Montel Williams is championing a new product that targets fat about your midsection. With swimsuit season right around the corner, could this product help you have the confidence to go from a one-piece to a bikini? First I had to ask myself why Montel Williams, a known TV-talk show host with no background in nutrition, [...]
read more

share

Related Posts


TV Host Montel Williams Wants To Help You Get High At His 'High End' Medical Marijuana Dispensary

Business & Finance : Business Insider: Money Game

The former host of "The Montel Williams Show" has a new job. Montel Williams is helping to launch a 'high end' medical marijuana dispensary in Sacramento, CA. Williams, a "long-time user of medical marijuana," hopes this can provide...

FTC: ‘Clinically Proven’ Menopause And Weight Loss Supplement Helps With Neither

Lifestyle / Shopping : The Consumerist

American consumers have spent $65 million on Amberen, a supplement meant to ease the symptoms of menopause and perimenopause. These symptoms can include hot flashes, insomnia, irritability, and weight gain. Did Amberen help with the...

Montel Williams Calls Medical Marijuana Opponents in Arkansas Racist

Politics / US Politics : Big Government

Talk show host Montel Williams is a vigorous supporter of medical marijuana. Williams uses the drug to combat symptoms from Multiple Sclerosis. And he isn't taking kindly to a new ad running in Arkansas that speaks out against bring...

GLA Supplements Show Promise for Weight Loss

Health / Weight Loss : Diets in Review

Mentioned on Dr. Oz recently in a discussion of long term weight loss in the midsection area, GLA is not an unknown to those in the weight loss arena. But many are unfamiliar with this supplement, which some have touted as the newes...

Targeted Drug Can ‘Diminish the Suffering’ of Myelofibrosis say Mayo Clinic Researchers

Health : Mayo Clinic News Blog

CHICAGO — Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase 3 clinical trial that tested...

Comments



Copyright © 2015 Regator, LLC